Severin Schwan

Roche CEO Severin Schwan isn’t about to tamper with a winning R&D strategy now, but he’s still looking for ways to cut costs
Roche CEO Severin Schwan isn’t about to tamper with a winning R&D strategy now, but he’s still looking for ways to cut costs
Endpoints
Roche
Pharma CEOs
Severin Schwan
R&D
Flag link:
Roche CEO Schwan concedes challenges as ‘highly, highly profitable’ drugs fall to biosimilar rivals
Roche CEO Schwan concedes challenges as ‘highly, highly profitable’ drugs fall to biosimilar rivals
Fierce Pharma
Roche
Pharma CEOs
Severin Schwan
biosimilars
Herceptin
Rituxan
Avastin
Flag link:
Roche and Novartis CEOs nab all-but-matching pay of 12M francs for 2016
Roche and Novartis CEOs nab all-but-matching pay of 12M francs for 2016
Fierce Pharma
Roche
Novartis
Pharma CEOs
executive pay
Severin Schwan
Joe Jimenez
Flag link:
Roche CEO Schwan beats Novartis chief with $12.3M in 2015 pay, but U.S. companies shell out more
Roche CEO Schwan beats Novartis chief with $12.3M in 2015 pay, but U.S. companies shell out more
Fierce Pharma
Roche
Novartis
executive pay
Severin Schwan
Joe Jimenez
Flag link:
Novartis, Roche CEOs see performance-based future, but U.S. isn't ready yet
Novartis, Roche CEOs see performance-based future, but U.S. isn't ready yet
Fierce Biotech
Novartis
Roche
Pharma CEOs
Amgen
Repatha
Joe Jimenez
Severin Schwan
Flag link:
Roche CEO: Big Data needs Big Pharma, and vice versa
Roche CEO: Big Data needs Big Pharma, and vice versa
Fierce Pharma
Roche
Big Pharma
Big Data
Severin Schwan
Flag link:
Roche is 'well placed' for U.S. pricing tussle, CEO says
Roche is 'well placed' for U.S. pricing tussle, CEO says
Fierce Pharma
Roche
drug pricing
Severin Schwan
Flag link:
Roche says biotech 'bubble' pushes midsize buys out of reach
Roche says biotech 'bubble' pushes midsize buys out of reach
Yahoo/Reuters
Roche
biotech
M&A
Severin Schwan
Flag link:
Roche Chief Takes Long View as Real's Slide, China Slowdown Hurt
Roche Chief Takes Long View as Real's Slide, China Slowdown Hurt
Bloomberg
Roche
Severin Schwan
emerging markets
China
Flag link:
Roche CEO Slams `Stupid' U.K. Decision to Drop Some Cancer Drugs
Roche CEO Slams `Stupid' U.K. Decision to Drop Some Cancer Drugs
Bloomberg
Roche
Pharma CEOs
UK
cancer
Avastin
Severin Schwan
Flag link:
For Roche CEO, celebrating failure is key to success
For Roche CEO, celebrating failure is key to success
Yahoo/Reuters
Roche
Pharma CEOs
Severin Schwan
Flag link:
Roche CEO Schwan took a hands-on approach negotiating $8.3B InterMune buyout
Roche CEO Schwan took a hands-on approach negotiating $8.3B InterMune buyout
Fierce Biotech
Roche
Pharma CEOs
Severin Schwan
M&A
InterMune
Flag link:
Roche CEO On Intermune Deal: 'This Is A Growth Story'
Roche CEO On Intermune Deal: 'This Is A Growth Story'
Forbes
Pharma CEOs
InterMune
Roche
M&A
Severin Schwan
Flag link:
Roche CEO: No appetite for expensive megadeals here
Roche CEO: No appetite for expensive megadeals here
Fierce Pharma
Pharma CEOs
Roche
Severin Schwan
M&A
Flag link:
Roche CEO would not exclude move into rare diseases
Roche CEO would not exclude move into rare diseases
Yahoo/Reuters
Roche
Severin Schwan
Pharma CEOs
Flag link:
[video]Roche looks to emerging markets for growth
[video]Roche looks to emerging markets for growth
CNBC
Roche
emerging markets
Severin Schwan
Flag link:
Roche CEO Says Drugmaker Isn’t Seeking Financing for Deal
Roche CEO Says Drugmaker Isn’t Seeking Financing for Deal
Bloomberg
Roche
Pharma CEOs
Severin Schwan
M&A
Biomarin
Flag link:
[video] Roche CEO on Illumina, DNA Sequencing, Euro Crisis
[video] Roche CEO on Illumina, DNA Sequencing, Euro Crisis
Marketwatch
DNA sequencing
Roche
Illumina
Pharma CEOs
Severin Schwan
Flag link:
Roche Is Open to $3 Billion Deal, Would ‘Seize’ Opportunity
Roche Is Open to $3 Billion Deal, Would ‘Seize’ Opportunity
Bloomberg Businessweek
Roche
M&A
Severin Schwan
Flag link:
CEO: Roche would consider more money-back deals
CEO: Roche would consider more money-back deals
Fierce Pharma
Avastin
Roche
Severin Schwan
Flag link:

Pages